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Mycotic iliac aneurysm associated with Burkholderia pseudomallei
Figure 1. MRI–angiography showing a saccular aneurysm of the left common iliac
artery.
Figure 2. Wrinkled colonies of Burkholderia pseudomallei visible after 72 h
incubation on chocolate agar at 37 8C.
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journa l homepage: www.e lsev ier .com/ locate / i j idA 60-year-old African man, without any signiﬁcant medical
history or immunodeﬁciency, was admitted to the hospital with a
one-week history of fever, jaundice, and abdominal pain. On
admission, he was febrile (temperature 40 8C) and tachypneic.
Physical examination revealed crepitant rales in the lung bases,
abdominal sensibility, with a maximum of pain, and a vascular
soufﬂe in the left ﬂank quadrant. Laboratory studies showed a
white blood cell count of 23.6  109 cells/l, increased C-reactive
protein (190 mg/l), and cholestasis with hyperbilirubinemia
(114mmol/l). Abdominal ultrasonographic examination and mag-
netic resonance imaging (MRI)–angiography showed a saccular
aneurysm in the left common iliac artery, measuring 55 mm in
transversal diameter (Figure 1). The diagnosis of mycotic
aneurysm was strongly suspected. Resection of the aneurysm
with implementation of an aorto-iliac allograft was realizedwithin
24 h. Blood and arterial cultures grew an unusual Gram-negative
bacillus, Burkholderia pseudomallei (Figure 2), the cause of vascular,
lung and liver melioidosis in our case. The patient’s clinical course
was favorable under parenteral antimicrobial therapy (imipenem1201-9712/$36.00 – see front matter  2009 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.07.008and ciproﬂoxacin) for 5 weeks, followed by oral antibiotic therapy
(trimethoprim–sulfamethoxazole) for 5months. At the last review,
6 months after stopping antibiotics, there was no clinical,
biological, or radiological evidence of relapse.
Mycotic aneurysms of the arterial system are rare and the usual
etiological agents implicated are Staphylococcus aureus and non-
typhoidal Salmonella species. Melioidosis is an infectious disease
caused by Burkholderia pseudomallei, which is endemic in South-
east Asia and northern Australia, and has also been reported from
non-endemic areas of the world. B. pseudomallei is an important
pathogen in humans and in a wide variety of animal species.1 In
France, the bacillus was ﬁrst isolated in 1975 from a Przewalski
horse; the origin of the contagion was determined to be horses
imported from Iran, an area where the disease has been recognized
in these animals since 1943.2,3 The most common clinical
presentation of melioidosis is pneumonia, followed by skin,
visceral, and genitourinary system abscesses. Melioidosis present-
ing as mycotic aneurysm has only rarely been reported and is
associated with high morbidity and mortality.4 In the absence of ases. Published by Elsevier Ltd. All rights reserved.
Medical Imagery / International Journal of Infectious Diseases 14S (2010) e381–e382e382severe purulent infection, repair using prosthetic grafts is
recommended; conversely, in the presence of a severe purulent
infection, an extra-anatomical bypass is generally required.5,6
Alongside the surgical management of mycotic aneurysm, the
treatment of choice is ceftazidime or imipenem, maintained until
clinical improvement, followed by oral treatment (trimethoprim–
sulfamethoxazole) for at least 3–6 months.6,7 Authors following
this therapeutic method did not note any relapse in the infection
during 1–2 years of surveillance; however, patients should be
followed closely for the rest of their lives in order to ensure an
optimal survival rate.6,8,9
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